120 related articles for article (PubMed ID: 12219774)
21. Clusterin expression in malignant lymphomas: a survey of 266 cases.
Saffer H; Wahed A; Rassidakis GZ; Medeiros LJ
Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802
[TBL] [Abstract][Full Text] [Related]
22. Analysis of gene expression profile of TPM3-ALK positive anaplastic large cell lymphoma reveals overlapping and unique patterns with that of NPM-ALK positive anaplastic large cell lymphoma.
Bohling SD; Jenson SD; Crockett DK; Schumacher JA; Elenitoba-Johnson KS; Lim MS
Leuk Res; 2008 Mar; 32(3):383-93. PubMed ID: 17720243
[TBL] [Abstract][Full Text] [Related]
23. CD30-positive T-cell lymphomas co-expressing CD15: an immunohistochemical analysis.
Gorczyca W; Tsang P; Liu Z; Wu CD; Dong HY; Goldstein M; Cohen P; Gangi M; Weisberger J
Int J Oncol; 2003 Feb; 22(2):319-24. PubMed ID: 12527929
[TBL] [Abstract][Full Text] [Related]
24. c-Jun expression and activation are restricted to CD30+ lymphoproliferative disorders.
Drakos E; Leventaki V; Schlette EJ; Jones D; Lin P; Medeiros LJ; Rassidakis GZ
Am J Surg Pathol; 2007 Mar; 31(3):447-53. PubMed ID: 17325487
[TBL] [Abstract][Full Text] [Related]
25. Immunoreactivity of B-cell markers (CD79a, L26) in rare cases of extranodal cytotoxic peripheral T- (NK/T-) cell lymphomas.
Blakolmer K; Vesely M; Kummer JA; Jurecka W; Mannhalter C; Chott A
Mod Pathol; 2000 Jul; 13(7):766-72. PubMed ID: 10912936
[TBL] [Abstract][Full Text] [Related]
26. Clinical role of Bcl-2, Bax, or p53 overexpression in peripheral T-cell lymphomas.
Jung JT; Kim DH; Kwak EK; Kim JG; Park TI; Sohn SK; Do YR; Kwon KY; Song HS; Park EH; Lee KB
Ann Hematol; 2006 Sep; 85(9):575-81. PubMed ID: 16673127
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders.
Benner MF; Jansen PM; Meijer CJ; Willemze R
Br J Dermatol; 2009 Jul; 161(1):121-7. PubMed ID: 19416236
[TBL] [Abstract][Full Text] [Related]
28. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.
Vose J; Armitage J; Weisenburger D;
J Clin Oncol; 2008 Sep; 26(25):4124-30. PubMed ID: 18626005
[TBL] [Abstract][Full Text] [Related]
29. Clusterin expression correlates with stage and presence of large cells in mycosis fungoides.
Chandra P; Plaza JA; Zuo Z; Diwan AH; Koeppen H; Duvic M; Medeiros LJ; Prieto VG
Am J Clin Pathol; 2009 Apr; 131(4):511-5. PubMed ID: 19289586
[TBL] [Abstract][Full Text] [Related]
30. Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study.
Piccaluga PP; Fuligni F; De Leo A; Bertuzzi C; Rossi M; Bacci F; Sabattini E; Agostinelli C; Gazzola A; Laginestra MA; Mannu C; Sapienza MR; Hartmann S; Hansmann ML; Piva R; Iqbal J; Chan JC; Weisenburger D; Vose JM; Bellei M; Federico M; Inghirami G; Zinzani PL; Pileri SA
J Clin Oncol; 2013 Aug; 31(24):3019-25. PubMed ID: 23857971
[TBL] [Abstract][Full Text] [Related]
31. Comparison of apoptosis and apoptosis-related gene products between extranodal oral B-cell lymphoma and maxillofacial nodal B-cell lymphoma.
Yin H; Okada N; Takagi M
J Oral Pathol Med; 2001 Mar; 30(3):141-7. PubMed ID: 11271628
[TBL] [Abstract][Full Text] [Related]
32. Aggressive peripheral T-cell lymphomas (specified and unspecified types).
Savage KJ
Hematology Am Soc Hematol Educ Program; 2005; ():267-77. PubMed ID: 16304391
[TBL] [Abstract][Full Text] [Related]
33. Revising the historical collection of epithelioid cell-rich lymphomas of the Kiel Lymph Node Registry: what is Lennert's lymphoma nowadays?
Hartmann S; Agostinelli C; Klapper W; Korkolopoulou P; Koch K; Marafioti T; Piccaluga PP; Patsouris E; Pileri S; Hansmann ML
Histopathology; 2011 Dec; 59(6):1173-82. PubMed ID: 22175897
[TBL] [Abstract][Full Text] [Related]
34. Intracellular TCR-signaling pathway: novel markers for lymphoma diagnosis and potential therapeutic targets.
Agostinelli C; Rizvi H; Paterson J; Shende V; Akarca AU; Agostini E; Fuligni F; Righi S; Spagnolo S; Piccaluga PP; Clark EA; Pileri SA; Marafioti T
Am J Surg Pathol; 2014 Oct; 38(10):1349-59. PubMed ID: 25118816
[TBL] [Abstract][Full Text] [Related]
35. [Molecular pathogenesis of peripheral T-cell lymphoma (1): angioimmunoblastic T-cell lymphoma, peripheral T-cell lymphoma, not otherwise specified and anaplastic large cell lymphoma].
Couronné L; Bastard C; Gaulard P; Hermine O; Bernard O
Med Sci (Paris); 2015 Oct; 31(10):841-52. PubMed ID: 26481023
[TBL] [Abstract][Full Text] [Related]
36. [Pathological diagnosis of mature T/NK cell lymphoma].
Ohshima K
Nihon Rinsho; 2014 Mar; 72(3):445-9. PubMed ID: 24724401
[TBL] [Abstract][Full Text] [Related]
37. Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network.
Herrera AF; Crosby-Thompson A; Friedberg JW; Abel GA; Czuczman MS; Gordon LI; Kaminski MS; Millenson MM; Nademanee AP; Niland JC; Rodig SJ; Rodriguez MA; Zelenetz AD; LaCasce AS
Cancer; 2014 Jul; 120(13):1993-9. PubMed ID: 24706502
[TBL] [Abstract][Full Text] [Related]
38. Peripheral T-Cell Lymphomas: Incorporating New Developments in Diagnostics, Prognostication, and Treatment Into Clinical Practice-PART 1: PTCL-NOS, FTCL, AITL, ALCL.
Zing NPC; Fischer T; Zain J; Federico M; Rosen ST
Oncology (Williston Park); 2018 Jul; 32(7):e74-e82. PubMed ID: 30080923
[TBL] [Abstract][Full Text] [Related]
39. A suggested immunohistochemical algorithm for the classification of T-cell lymphomas involving lymph nodes.
Vega F; Medeiros LJ
Hum Pathol; 2020 Aug; 102():104-116. PubMed ID: 32479842
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
